Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 40.49% is 101% above its 5-year average of -5622.03%, near the high end of its 5-year range (-100538.67%–104.11%).
8.27% below its 12-month average of 44.14%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 25.50%.
NET PROFIT MARGIN
40.49%
NET PROFIT MARGIN AVG TTM
44.14%
NET PROFIT MARGIN AVG 3Y
24.37%
NET PROFIT MARGIN AVG 5Y
-5622.03%
NET PROFIT MARGIN AVG 10Y
-9125.17%
NET PROFIT MARGIN AVG 15Y
-7311.73%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-8.27%
CURRENT VS 3Y AVG
+66.16%
CURRENT VS 5Y AVG
+100.72%
CURRENT VS 10Y AVG
+100.44%
CURRENT VS 15Y AVG
+100.55%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CorMedix Inc.
Market Cap
$566.84M
Net Profit Margin
40.49%
TTM Avg
44.14%
3Y Avg
24.37%
5Y Avg
-5622.03%
Market Cap
$564.94M
Net Profit Margin
-435.21%
TTM Avg
0.14%
3Y Avg
-46.77%
5Y Avg
-98.73%
Market Cap
$574.01M
Net Profit Margin
-144.63%
TTM Avg
-132.38%
3Y Avg
-98.61%
5Y Avg
-109.15%
Market Cap
$546.08M
Net Profit Margin
-921.50%
TTM Avg
-767.53%
3Y Avg
-527.58%
5Y Avg
-706.89%
Market Cap
$588.53M
Net Profit Margin
-26.05%
TTM Avg
-16.91%
3Y Avg
-17.17%
5Y Avg
5.54%
Market Cap
$544.69M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$542.67M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$591.53M
Net Profit Margin
-15.72%
TTM Avg
-17.63%
3Y Avg
-12.08%
5Y Avg
-18.54%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CorMedix Inc. (CRMD) | $566.84M | 40.49% | 44.14% | 24.37% | -5622.03% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $564.94M | -435.21% | 0.14% | -46.77% | -98.73% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $574.01M | -144.63% | -132.38% | -98.61% | -109.15% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $546.08M | -921.50% | -767.53% | -527.58% | -706.89% |
| Fulgent Genetics, Inc. (FLGT)vs › | $588.53M | -26.05% | -16.91% | -17.17% | 5.54% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $544.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $542.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| OrthoPediatrics Corp. (KIDS)vs › | $591.53M | -15.72% | -17.63% | -12.08% | -18.54% |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $540.00M | -41.34% | -365.72% | -7572.59% | -5048.40% |
Operating Margin
47.0%
Net Profit Margin
40.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 25.50% |
| 2026-03-31 | 30.29% |
| 2025-12-31 | 10.90% |
| 2025-09-30 | 104.11% |
| 2025-06-30 | 49.90% |
| 2025-03-31 | 52.82% |
| 2024-12-31 | 43.14% |
| 2024-09-30 | -24.24% |
| 2024-06-30 | -1755.51% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -27637.70% |
| 2022-09-30 | -100538.67% |
| 2022-06-30 | -35782.43% |
| 2022-03-31 | -92142.84% |
| 2021-12-31 | -13814.54% |
| 2021-09-30 | -22498.86% |
| 2021-06-30 | -56561.29% |
| 2021-03-31 | -8176.81% |
| 2020-12-31 | -10925.54% |
| 2020-09-30 | -7096.05% |
| 2020-06-30 | -23003.25% |
| 2020-03-31 | -7504.75% |
| 2019-12-31 | -21409.04% |
| 2019-09-30 | -8844.02% |
| 2019-06-30 | -1974.02% |
| 2019-03-31 | -3157.08% |
| 2018-12-31 | 8100.58% |
| 2018-09-30 | -2747.85% |
| 2018-06-30 | -113321.59% |
| 2018-03-31 | -43882.46% |
| 2017-12-31 | -11143.38% |
| 2017-09-30 | -16301.82% |
| 2017-06-30 | -3779.30% |
| 2017-03-31 | -19203.87% |
| 2016-12-31 | -5257.71% |
| 2016-09-30 | -20530.92% |
| 2016-06-30 | -29597.48% |
| 2016-03-31 | -10213.56% |
| 2015-12-31 | -16849.49% |
| 2015-09-30 | -13042.75% |
| 2015-06-30 | -3446.69% |
| 2015-03-31 | -17584.66% |
| 2014-12-31 | -2608.11% |
| 2014-09-30 | -9601.49% |
| 2014-06-30 | 8833.07% |
| 2014-03-31 | -136960.51% |
| 2013-12-31 | -170263.85% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
